FDA grants emergency use authorization to COVID-19 antibody drug | The Hill: Healthcare Policy

The Food and Drug Administration granted an emergency use authorization for a COVID-19 antibody drug made by GlaxoSmithKline (GSK). Sotrovimab, an investigational monoclonal antibody therapy, has been authorized for treating mild-to-moderate COVID-...